×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| LYKA LABS LTD. | 298.43 | 8.14 | 291.76 | 0.22 | 355.0 | 47.3 |
| ZENOTECH LABORATORIES LTD. | NA | NA | NA | NA | 340 | 81.6 |
| SMS Lifesciences India Ltd | 800.52 | 51.58 | 790.43 | 17.06 | 336 | 19.5 |
Lyka Labs Ltd.,, with Security Code 500259, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.5 | 21.2 | 26.8 | 31.4 | 27.0 | 30.1 | 41.2 | 32.9 | 30.5 | 29.2 |
| Expenses | 16.7 | 18.7 | 22.8 | 25.6 | 24.8 | 26.1 | 35.8 | 27.8 | 27.0 | 25.8 |
| Operating Profit | 2.7 | 2.6 | 3.9 | 5.9 | 2.2 | 4.1 | 5.3 | 5.1 | 3.5 | 3.4 |
| OPM % | 14.04% | 12.04% | 14.7% | 18.63% | 8.21% | 13.47% | 12.97% | 15.45% | 11.39% | 11.62% |
| Other Income | 0.5 | 0.4 | 0.3 | 0.5 | 0.4 | 0.6 | 0.1 | 0.9 | 0.7 | 0.7 |
| Interest | 2.8 | 1.3 | 1.2 | 1.3 | 1.0 | 0.7 | 0.5 | 0.6 | 0.5 | 0.9 |
| Depreciation | 3.3 | 3.3 | 3.5 | 2.7 | 2.8 | 1.7 | 1.7 | 1.8 | 1.3 | 2.0 |
| Profit before tax | -2.8 | -1.7 | -0.4 | 2.4 | -1.2 | 2.3 | 3.3 | 3.6 | 2.3 | 1.2 |
| Tax % | 2.6% | 2.2% | -33.4% | -43.2% | 33.8% | -25.4% | -24.3% | -24.8% | -39.6% | 30.5% |
| Net Profit | -3.0 | -1.7 | -0.3 | 1.4 | -1.6 | 1.8 | 2.5 | 2.7 | 1.3 | 0.8 |
| EPS in Rs | -1.05 | -0.54 | -0.1 | 0.4 | -0.5 | 0.49 | 0.69 | 0.75 | 0 | 0.22 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.8 | 22.2 | 22.9 | 28.0 | 32.6 | 27.8 | 30.1 | 41.2 | 33.8 | 33.4 |
| Expenses | 15.6 | 18.9 | 20.2 | 23.8 | 25.9 | 25.7 | 26.4 | 36.2 | 28.6 | 29.3 |
| Operating Profit | 2.2 | 3.3 | 2.6 | 4.2 | 6.6 | 2.0 | 3.7 | 5.0 | 5.2 | 4.1 |
| OPM % | 12.43% | 14.82% | 11.56% | 14.93% | 20.37% | 7.31% | 12.31% | 12.03% | 15.36% | 12.31% |
| Other Income | -5.9 | 0.0 | 0.4 | -0.2 | 0.5 | 0.3 | 0.6 | 0.0 | 0.8 | 0.8 |
| Interest | 3.1 | 2.8 | 1.4 | 1.2 | 1.3 | 1.1 | 0.6 | 0.5 | 0.6 | 0.5 |
| Depreciation | 3.5 | 3.5 | 3.5 | 3.6 | 2.8 | 2.9 | 1.8 | 1.8 | 1.8 | 1.4 |
| Profit before tax | -3.3 | -2.6 | -1.8 | -0.4 | 3.1 | -1.7 | 1.9 | 2.7 | 3.6 | 3.0 |
| Tax % | 2.3% | -0.1% | 7.3% | -22.3% | -38.7% | 28.2% | 30.8% | 28.5% | 24.3% | -29.8% |
| Net Profit | -10.5 | -3.0 | -1.9 | -0.6 | 1.8 | -2.1 | 1.3 | 2.1 | 2.7 | 2.0 |
| EPS in Rs | -3.64 | -1.05 | -0.57 | -0.16 | 0.53 | -3.83 | 0.4 | 0.58 | 0.75 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| TTM: | 33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 22% |
| TTM: | 251% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 50% |
| 3 Years: | -2% |
| 1 Year: | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 7% |
| 3 Years: | 19% |
| TTM: | 243% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 50% |
| 3 Years: | -2% |
| 1 Year: | 7% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|